Biotech
Companies in the biotech (biotechnology) space manufacture drugs, therapies, vaccines, and medical diagnostic tests for the treatment of health disorders and illnesses. Demand for biotechnology in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. The industry is considered one of the riskiest for investors as drug development success is a difficult and costly process.
Share This Page
Industry Rating
Loading, please wait...
Rk | Symbol | Name | Last | Day
Chg
| Mkt
Cap
| POWR
|
|---|---|---|---|---|---|---|
| 1 | OTSKY | Otsuka Holdings Co Ltd | 23.57 | -0.36 (-1.50%) | 25.32B | A |
| 2 | NPPNY | Nippon Shinyaku Co., Ltd. | 5.42 | -0.06 (-1.09%) | N/A | A |
| 3 | INCY | Incyte Corp. | 68.45 | 0.28 (0.41%) | 13.25B | A |
| 4 | GILD | Gilead Sciences Inc. | 111.75 | 0.24 (0.22%) | 139.01B | A |
| 5 | HRMY | Harmony Biosciences Holdings Inc. | 32.16 | 0.05 (0.16%) | 1.85B | A |
| 6 | PBYI | Puma Biotechnology Inc | 3.58 | 0.02 (0.56%) | 177.68M | B |
| 7 | BMRN | BioMarin Pharmaceutical Inc | 57.50 | 0.33 (0.58%) | 11.03B | A |
| 8 | GMAB | Genmab A/S ADR | 20.30 | -0.14 (-0.68%) | 13.02B | A |
| 9 | AMGN | Amgen Inc. | 298.24 | 1.39 (0.47%) | 160.37B | A |
| 10 | SGIOY | Shionogi & Co., Ltd. | 8.65 | -0.19 (-2.15%) | 14.72B | B |
| 11 | SBHMY | Sino Biopharmaceutical Limited | 9.48 | 0.69 (7.85%) | N/A | B |
| 12 | ILMN | Illumina Inc. | 100.80 | 0.46 (0.46%) | 15.96B | B |
| 13 | MNKD | MannKind Corporation | 3.60 | -0.02 (-0.55%) | 1.09B | B |
| 14 | CSBR | Champions Oncology, Inc. | 7.68 | -0.09 (-1.16%) | 106.19M | B |
| 15 | UCBJY | UCB SA | 96.19 | -2.08 (-2.12%) | 36.36B | B |
| 16 | EXEL | Exelixis, Inc. | 46.15 | 1.85 (4.18%) | 12.59B | B |
| 17 | BCRX | BioCryst Pharmaceuticals, Inc. | 8.94 | -0.08 (-0.89%) | 1.87B | B |
| 18 | PTCT | PTC Therapeutics, Inc. | 49.07 | -0.08 (-0.16%) | 3.89B | B |
| 19 | UTHR | United Therapeutics Corporation | 294.49 | -0.73 (-0.25%) | 13.28B | B |
| 20 | ALKS | Alkermes plc - Ordinary Shares | 28.85 | -0.15 (-0.52%) | 4.76B | B |
| 21 | INVA | Innoviva, Inc. | 19.21 | -0.19 (-0.98%) | 1.21B | B |
| 22 | LJPC | La Jolla Pharmaceutical Company | 6.22 | 0.00 (0.00%) | 155.11M | NR |
| 23 | HALO | Halozyme Therapeutics, Inc. | 54.00 | 0.16 (0.30%) | 6.65B | B |
| 24 | IMCR | Immunocore Holdings plc | 33.02 | 0.27 (0.82%) | 1.66B | B |
| 25 | XLO | Xilio Therapeutics, Inc. | 0.70 | 0.01 (0.72%) | 36.14M | B |
| 26 | KROS | Keros Therapeutics Inc. | 13.45 | 0.04 (0.30%) | 546.27M | B |
| 27 | MKKGY | Merck KGaA | 26.08 | -0.51 (-1.90%) | 16.85B | B |
| 28 | TBPH | Theravance Biopharma, Inc. - Ordinary Shares | 11.15 | 0.10 (0.90%) | 557.51M | B |
| 29 | ADAP | Adaptimmune Therapeutics plc | 0.25 | 0.01 (3.14%) | 66.26M | B |
| 30 | IPSC | Century Therapeutics, Inc. | 0.56 | 0.00 (0.02%) | 47.83M | B |
| 31 | BIIB | Biogen Inc. | 132.87 | -0.32 (-0.24%) | 19.47B | B |
| 32 | ACOR | Acorda Therapeutics, Inc. | 0.66 | -0.22 (-24.86%) | 820.96K | NR |
| 33 | VRTX | Vertex Pharmaceuticals Inc. | 459.62 | 2.59 (0.57%) | 118.03B | B |
| 34 | ALNY | Alnylam Pharmaceuticals Inc. | 331.91 | 2.14 (0.65%) | 43.28B | B |
| 35 | BDTX | Black Diamond Therapeutics Inc. | 2.58 | -0.02 (-0.77%) | 146.71M | B |
| 36 | STOK | Stoke Therapeutics Inc. | 11.48 | -0.07 (-0.61%) | 626.77M | B |
| 37 | EQ | Equillium, Inc. | 0.32 | 0.00 (0.78%) | 11.47M | B |
| 38 | ARWR | Arrowhead Pharmaceuticals, Inc. | 16.79 | -0.11 (-0.65%) | 2.32B | B |
| 39 | PLX | Protalix BioTherapeutics, Inc. (DE) | 1.54 | 0.04 (2.67%) | 122.59M | B |
| 40 | TAIPY | Taisho Pharmaceutical Holdings Company Ltd. | 14.00 | 2.00 (16.67%) | N/A | NR |
| 41 | TECH | Bio-Techne Corp | 53.14 | -0.04 (-0.08%) | 8.33B | B |
| 42 | GNFT | GENFIT S.A. | 3.87 | -0.02 (-0.51%) | 193.48M | NR |
| 43 | AVEO | AVEO Pharmaceuticals, Inc. | 15.00 | 0.00 (0.00%) | 521.45M | NR |
| 44 | VXRT | Vaxart Inc. | 0.43 | -0.01 (-2.51%) | 97.49M | C |
| 45 | DCPH | Deciphera Pharmaceuticals, Inc. | 25.59 | 0.02 (0.08%) | 2.21B | C |
| 46 | GOSS | Gossamer Bio, Inc. | 1.24 | 0.03 (2.48%) | 281.85M | C |
| 47 | JNCE | Jounce Therapeutics, Inc. | 1.88 | -0.05 (-2.59%) | 98.95M | NR |
| 48 | RPRX | Royalty Pharma PLC | 36.37 | 0.18 (0.50%) | 20.45B | C |
| 49 | FULC | Fulcrum Therapeutics, Inc. | 6.92 | -0.01 (-0.14%) | 373.53M | C |
| 50 | CRMD | CorMedix Inc. | 11.62 | 0.03 (0.26%) | 788.13M | C |
| 51 | TCON | TRACON Pharmaceuticals, Inc. | 0.03 | -0.01 (-25.98%) | 109.74K | C |
| 52 | TRDA | Entrada Therapeutics, Inc. | 7.23 | -0.04 (-0.55%) | 274.40M | C |
| 53 | ICPT | Intercept Pharmaceuticals, Inc. | 19.00 | 0.04 (0.21%) | 793.88M | NR |
| 54 | SIGA | SIGA Technologies Inc. | 6.69 | 0.01 (0.15%) | 477.94M | C |
| 55 | GLUE | Monte Rosa Therapeutics, Inc. | 4.87 | 0.14 (2.96%) | 299.55M | C |
| 56 | ORGO | Organogenesis Holdings Inc. | 4.25 | 0.20 (4.94%) | 539.13M | C |
| 57 | BDSI | BioDelivery Sciences International, Inc. | 5.59 | -0.01 (-0.18%) | 577.05M | NR |
| 58 | AYTU | Aytu BioScience, Inc. | 2.39 | 0.10 (4.37%) | 21.46M | C |
| 59 | EBS | Emergent Biosolutions, Inc. | 6.99 | -0.12 (-1.69%) | 379.40M | C |
| 60 | PRTK | Paratek Pharmaceuticals, Inc. | 2.23 | 0.04 (1.83%) | 127.83M | NR |
| 61 | ZYME | Zymeworks Inc. Common Shares | 13.04 | 0.15 (1.16%) | 907.28M | C |
| 62 | ATRA | Atara Biotherapeutics, Inc. | 8.47 | 0.22 (2.67%) | 50.49M | C |
| 63 | CORT | Corcept Therapeutics Incorporated | 72.27 | 0.93 (1.30%) | 7.66B | C |
| 64 | VCYT | Veracyte, Inc. | 27.51 | -0.07 (-0.25%) | 2.15B | C |
| 65 | ANIK | Anika Therapeutics Inc. | 11.25 | 0.00 (0.00%) | 161.34M | C |
| 66 | FOLD | Amicus Therapeutics, Inc. | 6.10 | 0.15 (2.52%) | 1.88B | C |
| 67 | KURA | Kura Oncology, Inc. | 5.86 | 0.05 (0.86%) | 507.33M | C |
| 68 | RGNX | REGENXBIO Inc. | 8.74 | 0.12 (1.39%) | 438.40M | C |
| 69 | MOLN | MOLECULAR PARTNERS AG | 3.76 | 0.05 (1.35%) | 151.81M | NR |
| 70 | SOLCF | SOL Global Investments Corp. | 0.06 | 0.00 (1.28%) | N/A | NR |
| 71 | AGEN | Agenus Inc. | 6.07 | 0.56 (10.16%) | 166.42M | C |
| 72 | BLPH | Bellerophon Therapeutics, Inc. | 0.01 | -0.00 (-25.47%) | 146.80K | NR |
| 73 | VNDA | Vanda Pharmaceuticals Inc. | 4.97 | 0.08 (1.64%) | 292.90M | C |
| 74 | REGN | Regeneron Pharmaceuticals Inc. | 547.36 | -0.38 (-0.07%) | 59.10B | C |
| 75 | BNTX | BioNTech SE ADR | 110.00 | 1.74 (1.61%) | 26.44B | C |
| 76 | CERS | Cerus Corporation | 1.54 | -0.02 (-1.28%) | 294.39M | C |
| 77 | JAZZ | Jazz Pharmaceuticals plc - Ordinary Shares | 109.45 | -0.47 (-0.43%) | 6.62B | C |
| 78 | ALLK | Allakos Inc. | 0.33 | -0.00 (-0.06%) | 29.74M | C |
| 79 | KRYS | Krystal Biotech, Inc. | 143.08 | 1.73 (1.22%) | 4.13B | C |
| 80 | SRZN | Surrozen, Inc | 8.36 | -0.38 (-4.35%) | 71.59M | C |
| 81 | VACC | Vaccitech plc | 5.00 | 0.51 (11.36%) | 192.74M | NR |
| 82 | XOMA | XOMA Corporation | 26.96 | 0.85 (3.26%) | 322.63M | C |
| 83 | CVAC | CureVac N.V | 5.45 | 0.05 (0.93%) | 1.22B | C |
| 84 | INFI | Infinity Pharmaceuticals, Inc. | 0.01 | -0.01 (-50.00%) | 719.28K | NR |
| 85 | FHTX | Foghorn Therapeutics, Inc. | 5.13 | 0.18 (3.64%) | 285.95M | C |
| 86 | IFRX | InflaRx N.V. | 0.80 | -0.01 (-1.06%) | 53.87M | C |
| 87 | VALN | Valneva SE | 5.81 | 0.00 (0.00%) | 494.40M | C |
| 88 | HRTX | Heron Therapeutics, Inc. | 2.20 | 0.05 (2.33%) | 335.64M | C |
| 89 | SELB | Selecta Biosciences, Inc. | 0.88 | -0.08 (-8.00%) | 136.77M | NR |
| 90 | PMCB | PharmaCyte Biotech Inc. | 1.11 | -0.03 (-2.63%) | 7.62M | NR |
| 91 | IMGN | ImmunoGen, Inc. | 31.23 | 0.00 (0.00%) | 8.32B | NR |
| 92 | GRPH | Graphite Bio, Inc. | 3.18 | -0.09 (-2.75%) | 185.19M | NR |
| 93 | MGNX | MacroGenics, Inc. | 1.46 | 0.08 (5.80%) | 92.11M | C |
| 94 | MIRO | Miromatrix Medical Inc. | 3.39 | 0.02 (0.59%) | 92.95M | NR |
| 95 | EVAX | Evaxion Biotech A/S | 2.39 | -0.08 (-3.24%) | 3.35M | C |
| 96 | THTX | Theratechnologies, Inc. | 3.20 | 0.84 (35.59%) | 147.14M | C |
| 97 | ADCT | ADC Therapeutics S.A. | 2.85 | 0.05 (1.79%) | 282.66M | C |
| 98 | ASND | Ascendis Pharma A/S | 174.18 | 1.08 (0.62%) | 10.65B | C |
| 99 | BGNE | BeiGene Ltd. ADR | 184.71 | 0.90 (0.49%) | 18.03B | C |
| 100 | NXTC | NextCure, Inc. | 0.44 | 0.01 (1.75%) | 12.22M | C |
| 101 | SEEL | Seelos Therapeutics, Inc. | 0.39 | -0.15 (-27.79%) | 145.08K | C |
| 102 | ANAB | AnaptysBio, Inc. | 23.75 | -0.13 (-0.54%) | 697.78M | C |
| 103 | LVTX | LAVA Therapeutics BV | 1.32 | 0.01 (0.76%) | 34.72M | C |
| 104 | IMRA | Imara Inc. | 50.44 | 0.49 (0.98%) | 16.14M | NR |
| 105 | GTHX | G1 Therapeutics, Inc. | 7.15 | 0.00 (0.00%) | 373.81M | C |
| 106 | BNTC | Benitec Biopharma Inc. | 13.17 | 0.43 (3.38%) | 345.71M | C |
| 107 | ADPT | Adaptive Biotechnologies Corporation | 11.80 | 0.32 (2.79%) | 1.79B | C |
| 108 | ANGN | Angion Biomedica Corp | 1.00 | 0.02 (2.04%) | 30.11M | NR |
| 109 | BOLT | Bolt Biotherapeutics, Inc. | 5.92 | 0.01 (0.17%) | 11.35M | C |
| 110 | CALA | Calithera Biosciences, Inc. | 0.00 | 0.00 (0.00%) | 0.49K | NR |
| 111 | ALVR | AlloVir Inc. | 9.81 | 0.15 (1.55%) | 49.47M | C |
| 112 | KZR | Kezar Life Sciences, Inc. | 4.58 | 0.09 (2.00%) | 33.46M | C |
| 113 | PASG | Passage Bio Inc. | 0.46 | 0.05 (13.51%) | 28.66M | C |
| 114 | CYT | Cyteir Therapeutics, Inc. | 3.02 | -0.07 (-2.27%) | 108.71M | NR |
| 115 | NVAX | Novavax, Inc. | 6.80 | 0.04 (0.59%) | 1.10B | C |
| 116 | CDAK | Codiak BioSciences Inc. | 0.06 | -0.07 (-55.98%) | 2.10M | NR |
| 117 | RPHM | Reneo Pharmaceuticals, Inc. | 1.82 | 0.09 (5.20%) | 60.83M | C |
| 118 | HLVX | HilleVax, Inc., | 2.06 | -0.05 (-2.37%) | 103.29M | C |
| 119 | AKBA | Akebia Therapeutics, Inc. | 3.62 | -0.01 (-0.28%) | 950.74M | C |
| 120 | CSLLY | CSL Ltd. ADR | 79.96 | 0.78 (0.99%) | 77.44B | C |
| 121 | ERAS | Erasca, Inc. | 1.44 | -0.01 (-0.69%) | 407.93M | C |
| 122 | ATAI | ATAI Life Sciences N.V. | 2.77 | 0.02 (0.73%) | 554.94M | C |
| 123 | SESN | Sesen Bio, Inc. | 0.63 | 0.04 (7.29%) | 127.96M | NR |
| 124 | HARP | Harpoon Therapeutics, Inc. | 23.01 | 0.02 (0.09%) | 389.61M | NR |
| 125 | ASLN | ASLAN Pharmaceuticals Limited | 0.60 | -0.10 (-14.27%) | 1.23M | NR |
| 126 | SGMO | Sangamo Therapeutics, Inc. | 0.53 | -0.01 (-1.51%) | 122.86M | C |
| 127 | DVAX | Dynavax Technologies Corporation | 10.27 | 0.11 (1.08%) | 1.23B | C |
| 128 | CGEN | Compugen Ltd. - Ordinary Shares | 1.76 | 0.02 (1.15%) | 157.06M | C |
| 129 | NBSE | NeuBase Therapeutics, Inc. | 0.38 | -0.01 (-3.20%) | 1.42M | NR |
| 130 | ITCI | Intra-Cellular Therapies Inc. | 131.87 | -0.05 (-0.04%) | 14.05B | C |
| 131 | AVIR | Atea Pharmaceuticals Inc. | 3.74 | 0.12 (3.17%) | 320.07M | C |
| 132 | MRKR | Marker Therapeutics, Inc. | 1.60 | 0.03 (1.91%) | 18.10M | C |
| 133 | ONCT | Oncternal Therapeutics, Inc. | 0.53 | -0.17 (-24.11%) | 1.56M | NR |
| 134 | CADL | Candel Therapeutics, Inc. | 5.10 | 0.11 (2.20%) | 255.53M | C |
| 135 | IPHA | INNATE PHARMA SA | 1.81 | -0.01 (-0.55%) | 166.84M | NR |
| 136 | IGMS | IGM BIOSCIENCES, INC. | 1.36 | 0.04 (3.03%) | 81.29M | C |
| 137 | CINC | CinCor Pharma, Inc., | 29.06 | -0.14 (-0.48%) | 1.27B | NR |
| 138 | SQZ | SQZ Biotechnologies Co. | 0.44 | 0.17 (61.11%) | 12.83M | NR |
| 139 | EPZM | Epizyme, Inc. | 1.47 | -0.02 (-1.34%) | 247.44M | NR |
| 140 | OBSV | ObsEva SA | 0.10 | -0.02 (-15.52%) | 7.94M | NR |
| 141 | BDSX | Biodesix Inc. | 0.27 | -0.00 (-1.24%) | 39.81M | C |
| 142 | APOP | Cellect Biotechnology Ltd. | 13.17 | 0.05 (0.38%) | 12.87M | NR |
| 143 | IOBT | IO Biotech, Inc. | 1.49 | 0.00 (0.00%) | 98.16M | C |
| 144 | RARE | Ultragenyx Pharmaceutical Inc. | 39.91 | 0.45 (1.14%) | 3.77B | C |
| 145 | PCSA | Processa Pharmaceuticals, Inc. | 0.19 | 0.01 (3.34%) | 2.32M | C |
| 146 | CTIC | CTI BioPharma Corp. | 9.09 | 0.00 (0.00%) | 1.20B | NR |
| 147 | AMRN | Amarin Corp. PLC ADR | 16.73 | 0.08 (0.48%) | 346.43M | C |
| 148 | MCRB | Seres Therapeutics, Inc. | 11.87 | 1.01 (9.30%) | 103.65M | C |
| 149 | GHRS | GH Research PLC | 14.91 | -0.11 (-0.77%) | 775.74M | C |
| 150 | TGTX | TG Therapeutics, Inc. | 36.72 | 0.43 (1.18%) | 5.83B | C |
| 151 | QLI | Qilian International Holding Group Limited | 5.41 | -0.35 (-6.08%) | 38.68M | NR |
| 152 | KMPH | KemPharm, Inc. | 5.81 | -0.02 (-0.34%) | 200.47M | NR |
| 153 | CASI | CASI Pharmaceuticals, Inc. | 1.30 | -0.03 (-2.28%) | 15.99M | C |
| 154 | SNSE | Sensei Biotherapeutics, Inc. | 9.03 | -0.24 (-2.54%) | 11.38M | C |
| 155 | ATHE | Alterity Therapeutics Limited | 4.15 | 0.11 (2.64%) | 36.80M | C |
| 156 | CNTB | Connect Biopharma Holdings Limited | 1.17 | 0.09 (8.27%) | 64.97M | C |
| 157 | KNTE | Kinnate Biopharma | 2.65 | -0.01 (-0.38%) | 125.15M | NR |
| 158 | PMVP | PMV Pharmaceuticals Inc. | 1.19 | 0.09 (8.18%) | 61.82M | C |
| 159 | TSVT | 2seventy bio Inc. | 5.00 | 0.01 (0.20%) | 266.15M | C |
| 160 | PNT | POINT Biopharma Global Inc., | 12.50 | 0.02 (0.16%) | 1.33B | NR |
| 161 | SGEN | Seagen Inc. | 228.74 | -0.16 (-0.07%) | 42.93B | NR |
| 162 | THRX | Theseus Pharmaceuticals, Inc. | 4.06 | 0.00 (0.00%) | 179.57M | NR |
| 163 | OCUP | Ocuphire Pharma Inc. | 1.17 | -0.16 (-12.03%) | 30.33M | C |
| 164 | STSA | SATSUMA PHARMACEUTICALS, INC. | 1.10 | -0.01 (-0.90%) | 36.47M | NR |
| 165 | DAWN | Day One Biopharmaceuticals, Inc. | 6.80 | 0.07 (1.04%) | 689.26M | C |
| 166 | OTIC | Otonomy, Inc. | 0.01 | -0.11 (-92.64%) | 582.48K | NR |
| 167 | NLTX | Neoleukin Therapeutics, Inc. | 3.49 | 0.05 (1.45%) | 32.80M | NR |
| 168 | TARS | Tarsus Pharmaceuticals Inc. | 41.15 | 0.70 (1.73%) | 1.73B | C |
| 169 | RVNC | Revance Therapeutics, Inc. | 3.65 | 0.01 (0.27%) | 381.02M | C |
| 170 | SEER | Seer Inc. Cl A | 2.27 | 0.06 (2.71%) | 133.63M | C |
| 171 | CLVS | Clovis Oncology, Inc. | 0.08 | -0.00 (-5.58%) | 11.77M | NR |
| 172 | CYCN | Cyclerion Therapeutics, Inc. | 3.36 | 0.06 (1.82%) | 10.79M | C |
| 173 | AVRO | AVROBIO, Inc. | 1.40 | -0.02 (-1.41%) | 62.85M | C |
| 174 | GBT | Global Blood Therapeutics, Inc. | 68.49 | 0.01 (0.01%) | 4.62B | NR |
| 175 | ANIP | ANI Pharmaceuticals, Inc. | 65.28 | 0.06 (0.09%) | 1.41B | C |
| 176 | KRON | Kronos Bio Inc. | 0.88 | 0.01 (1.49%) | 53.72M | C |
| 177 | ENLV | Enlivex Therapeutics Ltd. | 1.18 | 0.05 (4.42%) | 27.91M | C |
| 178 | VRNA | Verona Pharma plc - American Depositary Share | 91.53 | 1.45 (1.61%) | 7.42B | C |
| 179 | RGEN | Repligen Corporation | 127.47 | 0.51 (0.40%) | 7.16B | C |
| 180 | STTK | Shattuck Labs Inc. | 0.83 | -0.01 (-1.61%) | 39.92M | C |
| 181 | CRIS | Curis, Inc. | 1.81 | 0.06 (3.43%) | 18.94M | C |
| 182 | LUMO | Lumos Pharma, Inc. | 4.34 | 0.00 (0.00%) | 37.54M | C |
| 183 | GRTX | GALERA THERAPEUTICS, INC. | 0.03 | 0.00 (13.08%) | 2.22M | NR |
| 184 | NBY | NovaBay Pharmaceuticals, Inc. | 0.63 | 0.00 (0.62%) | 3.66M | C |
| 185 | ZNTL | Zentalis Pharmaceuticals Inc. | 1.26 | 0.02 (1.61%) | 90.66M | C |
| 186 | HSTO | Histogen Inc. | 0.22 | 0.00 (0.00%) | 918.05K | NR |
| 187 | BCEL | Atreca, Inc. - | 0.09 | -0.00 (-1.32%) | 3.57M | NR |
| 188 | LIAN | LianBio | 0.32 | -0.03 (-8.28%) | 34.47M | NR |
| 189 | DRNA | Dicerna Pharmaceuticals, Inc. | 38.22 | 0.22 (0.58%) | 2.99B | NR |
| 190 | CERT | Certara Inc. | 11.33 | -0.16 (-1.39%) | 1.84B | C |
| 191 | ANEB | Anebulo Pharmaceuticals, Inc. | 1.68 | -0.13 (-7.18%) | 69.02M | NR |
| 192 | BPMC | Blueprint Medicines Corporation | 128.35 | 0.15 (0.12%) | 8.29B | C |
| 193 | PSTI | Pluristem Therapeutics, Inc. | 1.00 | -0.03 (-2.91%) | 32.35M | NR |
| 194 | ANTX | AN2 Therapeutics, Inc., | 1.05 | -0.03 (-2.78%) | 31.68M | C |
| 195 | CCXI | ChemoCentryx, Inc. | 51.99 | 0.03 (0.06%) | 3.71B | NR |
| 196 | SPPI | Spectrum Pharmaceuticals, Inc. | 1.03 | 0.00 (0.00%) | 211.40M | NR |
| 197 | BNGO | Bionano Genomics, Inc. | 3.37 | -0.03 (-0.88%) | 11.34M | C |
| 198 | BBI | Brickell Biotech, Inc. | 2.35 | 0.05 (2.17%) | 6.75M | NR |
| 199 | ARGX | arGEN-X SE ADR | 543.48 | -1.63 (-0.30%) | 33.18B | C |
| 200 | FRLN | Freeline Therapeutics Holdings PLC ADR | 6.48 | 0.00 (0.00%) | 28.13M | NR |
| 201 | ESPR | Esperion Therapeutics, Inc. | 1.17 | 0.02 (1.74%) | 231.89M | C |
| 202 | TVTX | Travere Therapeutics, Inc. | 15.01 | 0.17 (1.15%) | 1.33B | C |
| 203 | CLSN | Celsion Corporation | 1.96 | 0.00 (0.00%) | 13.91M | NR |
| 204 | ARAV | Aravive, Inc. | 0.04 | -0.01 (-13.39%) | 2.95M | NR |
| 205 | TELA | TELA BIO, INC. | 2.04 | 0.13 (6.81%) | 80.69M | C |
| 206 | CLNN | Clene Inc. | 3.90 | -0.05 (-1.27%) | 35.03M | C |
| 207 | DBVT | DBV Technologies S.A. | 11.60 | 1.30 (12.62%) | 317.72M | C |
| 208 | INZY | Inozyme Pharma Inc. | 4.00 | 0.01 (0.25%) | 258.25M | C |
| 209 | NRXP | NRx Pharmaceuticals, Inc. | 3.38 | 0.06 (1.81%) | 58.44M | C |
| 210 | ARQT | Arcutis Biotherapeutics Inc. | 13.82 | 0.06 (0.44%) | 1.65B | C |
| 211 | GMTX | Gemini Therapeutics, Inc. | 1.35 | 0.00 (0.00%) | 58.49M | NR |
| 212 | VIGL | Vigil Neuroscience, Inc., | 7.99 | 0.01 (0.13%) | 381.02M | C |
| 213 | VECT | VectivBio Holding AG | 16.85 | 0.00 (0.00%) | 573.24M | NR |
| 214 | SGTX | Sigilon Therapeutics Inc. | 22.47 | -0.59 (-2.56%) | 56.49M | NR |
| 215 | ABUS | Arbutus Biopharma Corporation | 3.24 | 0.05 (1.57%) | 620.55M | C |
| 216 | SCPS | Scopus Biopharma Inc. | 0.00 | 0.00 (0.00%) | 12.63K | NR |
| 217 | PIRS | Pieris Pharmaceuticals, Inc. | 13.60 | -2.53 (-15.69%) | 17.95M | C |
| 218 | PRTA | Prothena Corporation plc - Ordinary Shares | 6.43 | 0.11 (1.82%) | 346.11M | C |
| 219 | GNLX | Genelux Corp. | 2.98 | 0.14 (4.93%) | 112.45M | C |
| 220 | MITO | Stealth BioTherapeutics Corp. - ADS | 0.32 | -0.00 (-1.36%) | 23.54M | NR |
| 221 | CYTR | CytRx Corporation | 0.09 | 0.00 (0.00%) | 4.14M | NR |
| 222 | TLGT | Teligent, Inc. | 0.17 | -0.03 (-13.85%) | 16.10M | NR |
| 223 | FNCH | Finch Therapeutics Group, Inc., | 13.08 | -0.13 (-0.95%) | 21.00M | NR |
| 224 | TALS | Talaris Therapeutics, Inc. | 2.72 | -0.02 (-0.73%) | 116.32M | NR |
| 225 | SPRB | Spruce Biosciences Inc. | 0.07 | -0.00 (-0.69%) | 3.06M | C |
| 226 | ENTA | Enanta Pharmaceuticals, Inc. | 7.89 | -0.08 (-1.00%) | 168.66M | C |
| 227 | REPH | Recro Pharma, Inc. | 2.09 | -0.01 (-0.48%) | 117.93M | NR |
| 228 | ALEC | Alector, Inc. | 1.51 | 0.01 (0.67%) | 150.99M | C |
| 229 | INBX | Inhibrx Inc. | 16.33 | 0.59 (3.75%) | 236.39M | C |
| 230 | SNSS | Sunesis Pharmaceuticals, Inc. | 5.32 | 1.04 (24.30%) | 96.25M | NR |
| 231 | VIR | VIR BIOTECHNOLOGY, INC. | 5.41 | -0.02 (-0.37%) | 747.87M | C |
| 232 | MACK | Merrimack Pharmaceuticals, Inc. | 15.13 | 0.00 (0.00%) | 223.74M | C |
| 233 | SABS | SAB Biotherapeutics, Inc., | 1.72 | -0.03 (-1.71%) | 15.98M | C |
| 234 | AURA | Aura Biosciences, Inc. | 6.56 | 0.10 (1.55%) | 329.76M | C |
| 235 | LEGN | Legend Biotech Corp. ADR | 35.64 | -0.27 (-0.75%) | 6.55B | C |
| 236 | MNOV | MediciNova, Inc. | 1.25 | -0.02 (-1.57%) | 61.31M | NR |
| 237 | RUBY | Rubius Therapeutics, Inc. | 0.06 | 0.00 (2.70%) | 5.16M | NR |
| 238 | HGEN | Humanigen, Inc. | 0.00 | -0.00 (-84.62%) | 23.82K | NR |
| 239 | IKNA | Ikena Oncology, Inc. | 1.33 | 0.02 (1.53%) | 64.18M | C |
| 240 | EDIT | Editas Medicine, Inc. | 2.57 | 0.01 (0.39%) | 215.14M | C |
| 241 | GALT | Galectin Therapeutics Inc. | 2.18 | 0.01 (0.46%) | 137.98M | C |
| 242 | CCCC | C4 Therapeutics Inc. | 1.48 | -0.04 (-2.63%) | 105.09M | C |
| 243 | AWH | Aspira Women's Health Inc. | 0.08 | -0.01 (-12.49%) | 2.44M | C |
| 244 | ELYM | Eliem Therapeutics, Inc. | 5.11 | -0.05 (-0.97%) | 152.03M | C |
| 245 | FBIO | Fortress Biotech, Inc. | 1.88 | 0.05 (2.73%) | 55.59M | C |
| 246 | GLS | Gelesis Holdings Inc., | 0.16 | 0.00 (0.38%) | 11.63M | NR |
| 247 | ATHX | Athersys, Inc. | 0.01 | -0.01 (-33.50%) | 833.21K | NR |
| 248 | PTE | PolarityTE, Inc. | 0.24 | -0.00 (-0.82%) | 1.78M | NR |
| 249 | COGT | Cogent Biosciences, Inc. | 7.58 | 0.17 (2.29%) | 863.03M | C |
| 250 | BTX | Brooklyn ImmunoTherapeutics Inc. | 7.36 | 0.07 (0.96%) | 432.96M | NR |
| 251 | BLTE | Belite Bio, Inc | 59.47 | 2.65 (4.67%) | 1.89B | C |
| 252 | DFFN | Diffusion Pharmaceuticals Inc. | 4.40 | 0.46 (11.68%) | 8.98M | NR |
| 253 | GERN | Geron Corporation | 1.43 | 0.03 (2.14%) | 910.79M | C |
| 254 | FATE | Fate Therapeutics, Inc. | 1.12 | 0.00 (0.00%) | 128.36M | C |
| 255 | AGIO | Agios Pharmaceuticals, Inc. | 36.07 | 0.72 (2.04%) | 2.09B | C |
| 256 | NK | NantKwest, Inc. | 32.49 | 4.21 (14.89%) | 3.55B | NR |
| 257 | MDNA | Medicenna Therapeutics Corp. | 0.16 | -0.02 (-13.16%) | 10.93M | NR |
| 258 | LYEL | Lyell Immunopharma, Inc. | 9.69 | 0.26 (2.76%) | 143.49M | C |
| 259 | RGLS | Regulus Therapeutics Inc. | 8.16 | 0.02 (0.25%) | 564.95M | C |
| 260 | XXII | 22nd Century Group, Inc. | 6.50 | -0.46 (-6.61%) | 3.29M | C |
| 261 | ATHA | Athira Pharma Inc. | 0.34 | 0.04 (12.92%) | 13.27M | C |
| 262 | SRNE | Sorrento Therapeutics Inc. | 0.00 | -0.00 (-7.14%) | 716.66K | NR |
| 263 | MRSN | Mersana Therapeutics, Inc. | 0.29 | 0.01 (3.50%) | 36.08M | C |
| 264 | LTRN | Lantern Pharma Inc. | 3.25 | 0.07 (2.20%) | 35.05M | D |
| 265 | URGN | UroGen Pharma Ltd. - Ordinary Shares | 13.58 | 0.62 (4.78%) | 626.13M | C |
| 266 | AKUS | Akouos Inc. | 13.29 | 0.14 (1.06%) | 490.88M | NR |
| 267 | KIN | Kindred Biosciences, Inc. | 9.25 | 0.01 (0.11%) | 420.52M | NR |
| 268 | SAGE | Sage Therapeutics, Inc. | 9.20 | 0.12 (1.32%) | 576.11M | D |
| 269 | LGND | Ligand Pharmaceuticals Incorporated | 114.58 | 0.92 (0.81%) | 2.21B | D |
| 270 | OMER | Omeros Corporation | 3.20 | 0.11 (3.56%) | 187.50M | D |
| 271 | MTNB | Matinas Biopharma Holdings, Inc. | 0.92 | -0.02 (-2.43%) | 4.67M | D |
| 272 | PRDS | Pardes Biosciences, Inc. | 2.16 | 0.00 (0.00%) | 133.95M | NR |
| 273 | NRBO | NeuroBo Pharmaceuticals Inc. | 2.36 | 0.01 (0.43%) | 20.33M | D |
| 274 | SRPT | Sarepta Therapeutics, Inc. | 18.24 | 0.05 (0.25%) | 1.79B | D |
| 275 | SBTX | Silverback Therapeutics Inc. | 5.87 | 0.06 (1.03%) | 211.66M | NR |
| 276 | UPC | Universe Pharmaceuticals INC | 3.70 | -0.12 (-3.14%) | 159.10K | D |
| 277 | DARE | Daré Bioscience, Inc. | 2.40 | 0.00 (0.00%) | 21.24M | D |
| 278 | CRVS | Corvus Pharmaceuticals, Inc. | 3.95 | -0.03 (-0.75%) | 269.27M | D |
| 279 | ONCS | OncoSec Medical Incorporated | 0.28 | 0.07 (31.87%) | 1.26M | NR |
| 280 | TWST | Twist Bioscience Corporation | 38.17 | 0.49 (1.30%) | 2.29B | D |
| 281 | VERV | Verve Therapeutics, Inc. | 11.28 | 0.07 (0.62%) | 1.01B | D |
| 282 | INAB | IN8bio, Inc. | 2.18 | 0.02 (0.93%) | 6.60M | D |
| 283 | NAUT | Nautilus Biotechnology, Inc. | 0.82 | 0.04 (4.73%) | 103.44M | D |
| 284 | NDRA | ENDRA Life Sciences Inc. | 3.54 | -0.06 (-1.67%) | 2.61M | D |
| 285 | TYRA | Tyra Biosciences, Inc. | 10.00 | -0.05 (-0.50%) | 530.90M | D |
| 286 | NERV | Minerva Neurosciences, Inc | 1.65 | -0.08 (-4.62%) | 11.54M | D |
| 287 | OVID | Ovid Therapeutics Inc. | 0.34 | 0.01 (2.39%) | 24.06M | D |
| 288 | HOWL | Werewolf Therapeutics, Inc. | 1.07 | 0.00 (0.00%) | 48.02M | D |
| 289 | ADXS | Advaxis, Inc. | 0.12 | 0.09 (261.26%) | 5.13M | NR |
| 290 | GANX | Gain Therapeutics, Inc. | 1.69 | 0.06 (3.36%) | 50.61M | D |
| 291 | GOVX | GeoVax Labs, Inc. | 0.48 | 0.00 (0.69%) | 7.65M | D |
| 292 | ADAG | Adagene Inc. | 1.85 | -0.09 (-4.64%) | 87.15M | D |
| 293 | PLRX | Pliant Therapeutics Inc. | 1.26 | 0.06 (5.00%) | 77.35M | D |
| 294 | MMEDF | Mind Medicine (MindMed) Inc. | 4.69 | 1.17 (33.24%) | N/A | NR |
| 295 | RLYB | Rallybio Corp | 0.33 | 0.01 (3.04%) | 13.84M | D |
| 296 | TSHA | Taysha Gene Therapies Inc. | 2.45 | 0.02 (0.82%) | 525.92M | D |
| 297 | HCWB | HCW Biologics Inc. | 4.06 | -0.11 (-2.64%) | 5.84M | D |
| 298 | EIGR | Eiger BioPharmaceuticals, Inc. | 1.73 | -0.18 (-9.21%) | 2.55M | NR |
| 299 | ENSC | Ensysce Biosciences, Inc | 2.31 | 0.04 (1.76%) | 5.48M | D |
| 300 | NHWK | NightHawk Biosciences, Inc., | 0.41 | 0.03 (8.96%) | 10.78M | NR |
| 301 | VCNX | Vaccinex, Inc. | 0.70 | -0.03 (-4.18%) | 1.82M | D |
| 302 | APRE | APREA THERAPEUTICS, INC. | 1.74 | 0.04 (2.35%) | 9.62M | NR |
| 303 | NMTR | 9 Meters Biopharma, Inc. | 0.07 | -0.05 (-42.97%) | 1.04M | NR |
| 304 | BPTS | Biophytis SA | 8.22 | -1.48 (-15.28%) | 2.89M | NR |
| 305 | RAIN | Rain Therapeutics Inc. | 3.34 | 0.07 (2.30%) | 25.34M | NR |
| 306 | VIRI | Virios Therapeutics, Inc. | 0.16 | 0.02 (12.40%) | 2.98M | NR |
| 307 | CNCE | Concert Pharmaceuticals, Inc. | 8.37 | 0.01 (0.12%) | 401.24M | NR |
| 308 | VLON | Vallon Pharmaceuticals, Inc. | 0.40 | -0.06 (-13.04%) | 5.39M | NR |
| 309 | DMAC | DiaMedica Therapeutics Inc. | 3.76 | 0.19 (5.32%) | 161.24M | D |
| 310 | RCUS | Arcus Biosciences, Inc. | 8.47 | -0.12 (-1.40%) | 896.85M | D |
| 311 | SRRK | Scholar Rock Holding Corporation | 35.99 | 0.44 (1.24%) | 3.42B | D |
| 312 | GRNA | GreenLight Biosciences Holdings, | 0.30 | -0.00 (-0.03%) | 45.43M | NR |
| 313 | CFRX | ContraFect Corporation | 0.05 | -0.02 (-27.95%) | 535.25K | NR |
| 314 | CYCC | Cyclacel Pharmaceuticals, Inc. | 0.24 | -0.01 (-4.80%) | 5.61M | D |
| 315 | XBIO | Xenetic Biosciences, Inc. | 3.70 | -0.24 (-6.09%) | 5.71M | NR |
| 316 | LBPS | 4D pharma plc | 1.65 | 0.04 (2.48%) | 27.11M | NR |
| 317 | XNCR | Xencor, Inc. | 8.42 | 0.12 (1.45%) | 599.26M | D |
| 318 | CBIO | Catalyst Biosciences, Inc. | 15.89 | 0.35 (2.22%) | 310.65M | NR |
| 319 | ATNF | 180 Life Sciences Corp. | 0.88 | -0.02 (-1.93%) | 5.34M | D |
| 320 | ONTX | Onconova Therapeutics, Inc. | 1.00 | -0.00 (-0.47%) | 20.90M | NR |
| 321 | PRTC | PureTech Health PLC | 18.01 | 0.80 (4.65%) | 432.58M | NR |
| 322 | ANCN | Anchiano Therapeutics Ltd. - American Depositary Share | 4.71 | 0.24 (5.37%) | 34.95M | NR |
| 323 | IMTX | Immatics N.V. | 5.71 | 0.12 (2.15%) | 694.05M | D |
| 324 | NGM | NGM Biopharmaceuticals, Inc. | 1.54 | -0.02 (-1.28%) | 128.53M | NR |
| 325 | LABP | Landos Biopharma, Inc. | 22.93 | 0.13 (0.58%) | 71.68M | D |
| 326 | INSM | Insmed, Inc. | 97.80 | -0.44 (-0.45%) | 18.55B | D |
| 327 | ANPC | AnPac Bio-Medical Science Co., Ltd. | 4.37 | -0.25 (-5.41%) | 4.23M | NR |
| 328 | ORPH | Orphazyme A/S ADR | 0.87 | -0.02 (-2.25%) | 30.72M | NR |
| 329 | BLI | Berkeley Lights Inc. | 1.20 | -0.08 (-5.88%) | 86.61M | NR |
| 330 | CANF | Can-Fite Biopharma Ltd Sponsored ADR (Israel) | 1.02 | -0.01 (-0.97%) | 3.61M | D |
| 331 | HTBX | Heat Biologics, Inc. | 2.38 | 0.01 (0.42%) | 61.05M | NR |
| 332 | CBAY | CymaBay Therapeutics Inc. | 32.48 | 0.01 (0.03%) | 3.73B | NR |
| 333 | PEPG | PepGen Inc., | 1.22 | 0.01 (0.83%) | 39.92M | D |
| 334 | MBIO | Mustang Bio, Inc. | 1.19 | -0.05 (-4.03%) | 5.21M | D |
| 335 | COCP | Cocrystal Pharma, Inc. | 1.52 | 0.01 (0.66%) | 15.46M | NR |
| 336 | NKTR | Nektar Therapeutics | 24.76 | -0.77 (-3.02%) | 307.20M | D |
| 337 | BIAF | bioAffinity Technologies Inc. | 0.27 | -0.02 (-6.07%) | 7.75M | D |
| 338 | ATOS | Atossa Genetics Inc. | 0.85 | 0.01 (1.43%) | 109.68M | D |
| 339 | BPTH | Bio-Path Holdings, Inc. | 0.17 | -0.00 (-2.29%) | 1.42M | D |
| 340 | ALDX | Aldeyra Therapeutics, Inc. | 4.30 | 0.30 (7.50%) | 257.55M | D |
| 341 | CARA | Cara Therapeutics, Inc. | 5.32 | -0.23 (-4.14%) | 24.33M | D |
| 342 | AMTI | Applied Molecular Transport Inc. | 0.26 | -0.04 (-14.30%) | 10.87M | NR |
| 343 | VBIV | VBI Vaccines, Inc. - Ordinary Shares | 0.07 | -0.07 (-50.87%) | 1.87M | NR |
| 344 | TNYA | Tenaya Therapeutics, Inc. | 0.61 | -0.00 (-0.15%) | 99.54M | D |
| 345 | VYNE | VYNE Therapeutics Inc. | 1.43 | -0.09 (-5.63%) | 21.67M | D |
| 346 | CMRX | Chimerix, Inc. | 8.54 | -0.01 (-0.12%) | 801.09M | D |
| 347 | AVXL | Anavex Life Sciences Corp. | 10.79 | 0.22 (2.08%) | 921.16M | D |
| 348 | IMNM | Immunome Inc. | 8.84 | 0.21 (2.43%) | 769.19M | D |
| 349 | BCDA | BioCardia, Inc. | 2.12 | 0.04 (1.73%) | 10.98M | D |
| 350 | VCEL | Vericel Corporation | 41.74 | 0.28 (0.68%) | 2.10B | D |
| 351 | LMNL | Liminal Biosciences Inc. | 8.50 | 0.01 (0.12%) | 26.38M | NR |
| 352 | IDRA | Idera Pharmaceuticals, Inc. | 0.43 | -0.12 (-21.57%) | 26.50M | NR |
| 353 | ANNX | Annexon Inc. | 2.89 | 0.08 (2.85%) | 317.07M | D |
| 354 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. Common Shares | 14.63 | -0.13 (-0.88%) | 1.49B | D |
| 355 | XLRN | Acceleron Pharma Inc. | 178.75 | -0.93 (-0.52%) | 10.93B | NR |
| 356 | RAPT | RAPT THERAPEUTICS, INC. | 8.05 | 0.04 (0.50%) | 133.11M | D |
| 357 | ENTX | Entera Bio Ltd | 1.89 | -0.02 (-1.04%) | 85.91M | D |
| 358 | ADMA | ADMA Biologics Inc | 18.28 | 0.14 (0.77%) | 4.36B | D |
| 359 | SRRA | Sierra Oncology, Inc. | 54.99 | 0.02 (0.04%) | 1.34B | NR |
| 360 | PHIO | Phio Pharmaceuticals Corp | 2.40 | -0.08 (-3.23%) | 11.52M | D |
| 361 | DNA | Ginkgo Bioworks Holdings, Inc. | 12.72 | 0.06 (0.47%) | 744.53M | D |
| 362 | XFOR | X4 Pharmaceuticals, Inc. | 1.89 | -0.09 (-4.55%) | 10.94M | D |
| 363 | PULM | Pulmatrix, Inc. | 6.53 | -0.47 (-6.71%) | 23.83M | D |
| 364 | BIVI | BioVie Inc. | 0.96 | -0.01 (-1.07%) | 17.83M | D |
| 365 | GNPX | Genprex, Inc. | 0.26 | -0.01 (-3.59%) | 7.24M | D |
| 366 | IPA | ImmunoPrecise Antibodies Ltd. | 1.31 | 0.25 (23.58%) | 59.95M | D |
| 367 | PAND | Pandion Therapeutics Inc. | 60.05 | 0.13 (0.22%) | 1.77B | NR |
| 368 | ICVX | Icosavax, Inc. | 15.31 | -0.14 (-0.91%) | 766.88M | NR |
| 369 | THRD | Third Harmonic Bio Inc. | 5.43 | 0.01 (0.18%) | 245.05M | D |
| 370 | MRNS | Marinus Pharmaceuticals, Inc. | 0.55 | -0.00 (-0.16%) | 30.32M | D |
| 371 | CLBS | Caladrius Biosciences, Inc. | 0.43 | -0.08 (-16.44%) | 25.83M | NR |
| 372 | ACXP | Acurx Pharmaceuticals, Inc. | 0.48 | -0.00 (-0.97%) | 11.32M | D |
| 373 | FMTX | Forma Therapeutics Holdings Inc. | 20.01 | 0.03 (0.15%) | 957.54M | NR |
| 374 | POAI | Predictive Oncology Inc. | 0.85 | 0.02 (1.89%) | 7.59M | D |
| 375 | RCKT | Rocket Pharmaceuticals, Inc. | 2.90 | 0.02 (0.69%) | 309.68M | D |
| 376 | AMAM | Ambrx Biopharma Inc. | 28.00 | 0.02 (0.07%) | 1.77B | NR |
| 377 | ABOS | Acumen Pharmaceuticals, Inc. | 1.16 | 0.03 (2.65%) | 70.26M | D |
| 378 | AGTC | Applied Genetic Technologies Corporation | 0.39 | 0.00 (1.23%) | 26.62M | NR |
| 379 | KDNY | Chinook Therapeutics, Inc. | 40.39 | 0.09 (0.22%) | 2.90B | NR |
| 380 | KTRA | Kintara Therapeutics, Inc. | 0.22 | -0.01 (-6.31%) | 11.91M | NR |
| 381 | PHVS | Pharvaris N.V. | 18.60 | 0.78 (4.38%) | 972.59M | D |
| 382 | OTLK | Outlook Therapeutics, Inc. | 1.78 | 0.07 (4.09%) | 59.75M | D |
| 383 | UBX | Unity Biotechnology, Inc. | 0.29 | -0.01 (-1.71%) | 5.04M | D |
| 384 | BCLI | Brainstorm Cell Therapeutics Inc. | 1.16 | -0.01 (-0.85%) | 11.41M | D |
| 385 | GLMD | Galmed Pharmaceuticals Ltd. | 1.83 | 0.02 (0.83%) | 3.02M | D |
| 386 | BLU | BELLUS Health Inc. | 14.74 | 0.00 (0.00%) | 1.87B | NR |
| 387 | JAGX | Jaguar Health, Inc. | 2.58 | 0.01 (0.39%) | 2.63M | D |
| 388 | NUVL | Nuvalent, Inc. | 80.48 | -0.02 (-0.02%) | 5.78B | D |
| 389 | DSGN | Design Therapeutics, Inc. | 3.77 | 0.09 (2.45%) | 214.02M | D |
| 390 | KOD | Kodiak Sciences Inc | 3.95 | 0.12 (3.13%) | 208.42M | D |
| 391 | RNAZ | TransCode Therapeutics, Inc., | 8.45 | 0.16 (1.93%) | 7.04M | D |
| 392 | ORMP | Oramed Pharmaceuticals Inc. | 2.18 | 0.02 (0.93%) | 89.05M | D |
| 393 | EVLO | Evelo Biosciences, Inc. | 0.00 | 0.00 (0.00%) | 9.49K | NR |
| 394 | IMPL | IMPEL NEUROPHARMA INC | 0.04 | -0.02 (-27.27%) | 956.00K | NR |
| 395 | IMV | IMV Inc. | 0.82 | -0.02 (-2.55%) | 9.63M | NR |
| 396 | ENVB | Enveric Biosciences Inc. | 1.26 | 0.01 (0.80%) | 3.11M | D |
| 397 | GNCA | Genocea Biosciences, Inc. | 0.00 | 0.00 (0.00%) | 5.87K | NR |
| 398 | FREQ | FREQUENCY THERAPEUTICS, INC. | 0.30 | 0.02 (5.94%) | 10.94M | NR |
| 399 | TARA | Protara Therapeutics, Inc. | 2.89 | 0.11 (3.96%) | 111.50M | D |
| 400 | SYN | Synthetic Biologics, Inc. | 1.02 | 0.01 (0.99%) | 16.16M | NR |
| 401 | TCBP | TC BioPharm (Holdings) PLC ADR | 0.50 | -1.04 (-67.53%) | 205.00K | D |
| 402 | BLRX | BioLineRx Ltd. | 4.49 | -0.12 (-2.60%) | 19.14M | D |
| 403 | DRTS | Alpha Tau Medical Ltd., | 3.17 | 0.00 (0.00%) | 268.88M | D |
| 404 | RVMD | Revolution Medicines Inc. | 37.87 | 0.68 (1.83%) | 7.05B | D |
| 405 | ABIO | ARCA biopharma, Inc. | 2.40 | -0.10 (-4.00%) | 34.82M | D |
| 406 | VTYX | Ventyx Biosciences, Inc. | 2.08 | 0.06 (2.97%) | 148.01M | D |
| 407 | LXRX | Lexicon Pharmaceuticals, Inc. | 0.90 | -0.01 (-1.63%) | 325.70M | D |
| 408 | CATB | Catabasis Pharmaceuticals, Inc. | 8.54 | -0.64 (-6.97%) | 33.34M | NR |
| 409 | ELDN | Eledon Pharmaceuticals, Inc. | 3.08 | 0.02 (0.65%) | 184.44M | D |
| 410 | DTIL | Precision BioSciences, Inc. | 4.34 | 0.08 (1.88%) | 48.12M | D |
| 411 | GLYC | GlycoMimetics, Inc. | 0.16 | -0.01 (-5.42%) | 10.13M | D |
| 412 | CVM | Cel-Sci Corporation | 2.49 | -0.03 (-1.19%) | 7.55M | D |
| 413 | MREO | Mereo BioPharma Group plc (Mereo) | 2.87 | 0.00 (0.00%) | 456.33M | D |
| 414 | CNTX | Context Therapeutics Inc. | 0.64 | 0.01 (1.33%) | 57.43M | D |
| 415 | TTNP | Titan Pharmaceuticals, Inc. | 4.40 | 0.05 (1.15%) | 4.02M | NR |
| 416 | IMGO | Imago BioSciences, Inc. | 36.01 | 0.01 (0.03%) | 1.22B | NR |
| 417 | GLPG | Galapagos NV | 28.83 | 0.28 (0.98%) | 1.90B | D |
| 418 | AIKI | AIkido Pharma Inc. | 3.56 | 0.01 (0.28%) | 19.53M | NR |
| 419 | BCAB | BioAtla, Inc. | 0.38 | -0.02 (-5.43%) | 21.97M | D |
| 420 | COYA | Coya Therapeutics Inc. | 5.96 | 0.18 (3.11%) | 99.68M | D |
| 421 | FGEN | FibroGen, Inc | 5.61 | 0.36 (6.86%) | 22.68M | D |
| 422 | FPRX | Five Prime Therapeutics, Inc. | 38.00 | 0.01 (0.03%) | 1.77B | NR |
| 423 | JANX | Janux Therapeutics, Inc. | 24.45 | 0.39 (1.62%) | 1.45B | D |
| 424 | DRMA | Dermata Therapeutics, Inc. | 0.66 | -0.00 (-0.45%) | 4.23M | D |
| 425 | MBRX | Moleculin Biotech, Inc. | 0.34 | -0.01 (-2.16%) | 4.80M | D |
| 426 | PDSB | PDS Biotechnology Corporation | 1.33 | 0.06 (4.72%) | 60.79M | D |
| 427 | PALI | Palisade Bio Inc. | 0.73 | -0.00 (-0.62%) | 3.48M | D |
| 428 | PSNL | Personalis, Inc. | 7.45 | -0.06 (-0.73%) | 658.02M | D |
| 429 | NCNA | NuCana plc - American Depositary Share | 0.05 | -0.00 (-5.13%) | 325.73K | D |
| 430 | FWP | Forward Pharma A/S | 1.95 | 0.14 (7.73%) | 13.83M | NR |
| 431 | ADVM | Adverum Biotechnologies, Inc. | 2.28 | 0.02 (0.88%) | 47.63M | D |
| 432 | AYLA | Ayala Pharmaceuticals Inc. | 0.50 | 0.03 (5.84%) | 7.46M | NR |
| 433 | KZIA | Kazia Therapeutics Limited | 6.75 | 0.17 (2.58%) | 6.80M | D |
| 434 | OYST | OYSTER POINT PHARMA, INC. | 11.17 | 0.02 (0.18%) | 299.85M | NR |
| 435 | VAXX | Vaxxinity, Inc. | 0.03 | 0.03 (29,900.00%) | 3.80M | NR |
| 436 | ONCY | Oncolytics Biotech Inc. | 0.92 | 0.13 (16.81%) | 86.73M | D |
| 437 | CGTX | Cognition Therapeutics | 0.41 | 0.07 (20.82%) | 25.11M | D |
| 438 | TNXP | Tonix Pharmaceuticals Holding Corp. | 35.48 | 0.31 (0.88%) | 261.03M | D |
| 439 | AEZS | Aeterna Zentaris Inc. | 5.72 | 0.32 (5.93%) | 10.26M | NR |
| 440 | LCTX | Lineage Cell Therapeutics, Inc. | 1.01 | -0.01 (-0.98%) | 230.64M | D |
| 441 | PSTV | PLUS THERAPEUTICS, Inc. | 0.30 | -0.01 (-3.52%) | 15.12M | D |
| 442 | CHRS | Coherus BioSciences, Inc. | 0.81 | 0.01 (1.87%) | 93.91M | D |
| 443 | ARDX | Ardelyx, Inc. | 4.27 | 0.08 (1.91%) | 1.02B | D |
| 444 | KDMN | Kadmon Holdings, Inc. | 9.50 | 0.02 (0.21%) | 1.70B | NR |
| 445 | EQRX | EQRx, Inc. | 2.34 | -0.05 (-2.09%) | 1.14B | NR |
| 446 | NKTX | Nkarta Inc. | 1.75 | 0.01 (0.57%) | 124.18M | D |
| 447 | MTP | Midatech Pharma PLC | 0.29 | -0.06 (-18.52%) | 6.18M | NR |
| 448 | VTGN | VistaGen Therapeutics, Inc. | 2.00 | -0.04 (-1.96%) | 58.32M | D |
| 449 | UNCY | Unicycive Therapeutics, Inc., | 4.60 | -0.04 (-0.86%) | 58.15M | D |
| 450 | CLXT | Calyxt, Inc. | 6.30 | 0.33 (5.53%) | 31.34M | NR |
| 451 | NNVC | NanoViricides, Inc. NEW | 1.38 | -0.01 (-0.72%) | 22.18M | D |
| 452 | EFTR | eFFECTOR Therapeutics, Inc. | 0.00 | -0.00 (-33.33%) | 0.94K | D |
| 453 | TCRR | TCR2 Therapeutics Inc. | 1.48 | -0.09 (-5.73%) | 58.11M | NR |
| 454 | ALZN | Alzamend Neuro, Inc. | 2.94 | -0.06 (-2.00%) | 2.35M | D |
| 455 | OMGA | Omega Therapeutics, Inc. | 0.14 | -0.02 (-10.82%) | 7.90M | D |
| 456 | EDSA | Edesa Biotech, Inc. | 2.08 | 0.04 (1.96%) | 14.61M | NR |
| 457 | SLS | SELLAS Life Sciences Group, Inc. | 2.17 | 0.05 (2.36%) | 216.52M | D |
| 458 | CBLI | Cleveland BioLabs, Inc. | 3.17 | -0.25 (-7.31%) | 49.07M | NR |
| 459 | IKT | Inhibikase Therapeutics Inc. | 1.89 | 0.04 (2.16%) | 140.51M | D |
| 460 | AGE | AgeX Therapeutics, Inc. | 11.10 | -1.50 (-11.90%) | 11.97M | NR |
| 461 | INO | Inovio Pharmaceuticals Inc. | 1.33 | -0.81 (-37.85%) | 48.78M | D |
| 462 | TLSA | Tiziana Life Sciences plc - American Depository Share | 1.51 | -0.06 (-3.82%) | 176.44M | D |
| 463 | CMPX | Compass Therapeutics Inc. | 2.78 | 0.16 (6.11%) | 384.43M | D |
| 464 | NWBO | Northwest Bioth Cmn | 0.25 | 0.00 (0.85%) | 361.97M | D |
| 465 | GRTS | Gritstone Oncology, Inc. | 0.03 | -0.02 (-31.78%) | 3.50M | D |
| 466 | TRVN | Trevena, Inc. | 0.94 | -0.16 (-14.55%) | 901.46K | D |
| 467 | VSTM | Verastem, Inc. | 4.80 | -0.05 (-1.03%) | 263.76M | D |
| 468 | MNPR | MONOPAR THERAPEUTICS | 36.25 | 1.09 (3.10%) | 221.67M | D |
| 469 | NUVB | Nuvation Bio Inc. | 2.09 | 0.04 (1.95%) | 711.15M | D |
| 470 | CRBU | Caribou Biosciences, Inc. | 1.37 | 0.00 (0.00%) | 127.42M | D |
| 471 | AGLE | Aeglea BioTherapeutics, Inc. | 12.01 | 0.97 (8.79%) | 48.63M | NR |
| 472 | EVFM | Evofem Biosciences, Inc. | 0.01 | 0.00 (0.00%) | 1.19M | NR |
| 473 | CGEM | Cullinan Oncology Inc. | 7.81 | 0.05 (0.64%) | 460.91M | D |
| 474 | ATNM | Actinium Pharmaceuticals, Inc. (Delaware) | 1.44 | 0.01 (0.70%) | 44.92M | D |
| 475 | RLMD | Relmada Therapeutics, Inc. | 0.63 | 0.03 (4.81%) | 20.91M | D |
| 476 | PRQR | ProQR Therapeutics N.V. - Ordinary Shares | 2.18 | 0.05 (2.35%) | 229.36M | D |
| 477 | AVTE | Aerovate Therapeutics, Inc. | 2.68 | 0.00 (0.00%) | 77.68M | D |
| 478 | CWBR | CohBar, Inc. | 0.41 | 0.00 (0.00%) | 1.19M | NR |
| 479 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 0.36 | -0.03 (-6.49%) | 17.28M | D |
| 480 | ELEV | Elevation Oncology, Inc. | 0.39 | 0.01 (2.46%) | 22.98M | D |
| 481 | BNOX | Bionomics Limited, | 0.25 | 0.01 (4.20%) | 4.47M | D |
| 482 | KYMR | Kymera Therapeutics Inc. | 44.79 | 0.26 (0.58%) | 2.92B | D |
| 483 | INKT | MiNK Therapeutics, Inc. | 7.23 | 0.06 (0.86%) | 28.82M | NR |
| 484 | FBRX | Forte Biosciences, Inc. | 13.66 | -0.18 (-1.30%) | 89.92M | D |
| 485 | LBPH | Longboard Pharmaceuticals, Inc., | 59.98 | 0.02 (0.03%) | 2.34B | D |
| 486 | TMBR | Timber Pharmaceuticals, Inc. | 0.35 | 0.01 (3.09%) | 1.21M | NR |
| 487 | VIE | VIELA BIO, INC. | 53.01 | 0.00 (0.00%) | 2.91B | NR |
| 488 | MRNA | Moderna Inc. | 30.49 | 0.21 (0.69%) | 11.79B | D |
| 489 | BLCM | Bellicum Pharmaceuticals, Inc. | 0.07 | -0.01 (-6.62%) | 726.83K | NR |
| 490 | SWTX | SPRINGWORKS THERAPEUTICS, INC. | 46.99 | 0.01 (0.02%) | 3.54B | D |
| 491 | MORF | Morphic Holding, Inc. | 56.99 | 0.02 (0.04%) | 2.85B | D |
| 492 | PLXP | PLx Pharma, Inc. | 0.02 | 0.00 (0.00%) | 603.16K | NR |
| 493 | EWTX | Edgewise Therapeutics, Inc. | 13.03 | 0.02 (0.15%) | 1.37B | D |
| 494 | ONCR | Oncorus Inc. | 0.13 | -0.00 (-3.08%) | 3.29M | NR |
| 495 | ALGS | Aligos Therapeutics Inc. | 7.84 | 0.53 (7.25%) | 47.93M | D |
| 496 | PRPO | Precipio, Inc. | 12.05 | 0.75 (6.67%) | 18.22M | NR |
| 497 | CLGN | CollPlant Biotechnologies Ltd. | 1.38 | -0.04 (-2.54%) | 17.60M | NR |
| 498 | CERE | Ceres Inc | 44.96 | 0.33 (0.74%) | 8.19B | NR |
| 499 | SLDB | Solid Biosciences Inc. | 5.03 | 0.16 (3.29%) | 389.90M | D |
| 500 | MRUS | Merus N.V. | 53.82 | 0.49 (0.92%) | 3.73B | D |
| 501 | HEPA | Hepion Pharmaceuticals, Inc. | 0.07 | -0.00 (-0.44%) | 737.57K | D |
| 502 | AMPE | Ampio Pharmaceuticals, Inc. | 0.00 | -0.00 (-96.30%) | 0.11K | NR |
| 503 | ORIC | Oric Pharmaceuticals Inc. | 10.80 | 0.15 (1.41%) | 920.42M | D |
| 504 | ALRN | Aileron Therapeutics, Inc. | 2.11 | 0.18 (9.33%) | 45.72M | D |
| 505 | MLTX | MoonLake Immunotherapeutics, | 48.89 | 1.03 (2.15%) | 3.13B | D |
| 506 | XBIT | XBiotech Inc. | 3.18 | -0.04 (-1.24%) | 96.95M | D |
| 507 | IMUX | Immunic, Inc. | 0.73 | 0.01 (1.99%) | 69.68M | D |
| 508 | CRTX | Cortexyme, Inc. | 1.95 | 0.05 (2.63%) | 58.79M | NR |
| 509 | EARS | Auris Medical Holding Ltd. | 3.05 | -0.05 (-1.77%) | 34.82M | NR |
| 510 | ZIOP | ZIOPHARM Oncology Inc | 0.87 | -0.01 (-0.88%) | 187.12M | NR |
| 511 | ACHV | Achieve Life Sciences, Inc. | 2.18 | -0.08 (-3.54%) | 75.61M | D |
| 512 | ADGI | Adagio Therapeutics, Inc. | 4.64 | 0.04 (0.87%) | 504.98M | NR |
| 513 | IMMP | Immutep Limited | 1.72 | 0.02 (1.18%) | 251.19M | D |
| 514 | ARTL | Artelo Biosciences, Inc. | 10.05 | -0.98 (-8.88%) | 5.50M | NR |
| 515 | OLMA | Olema Pharmaceuticals | 4.57 | 0.03 (0.66%) | 312.68M | D |
| 516 | GLTO | Galecto Inc. | 3.54 | 0.00 (0.00%) | 4.68M | D |
| 517 | CERC | Cerecor Inc. | 2.93 | -0.05 (-1.68%) | 281.31M | NR |
| 518 | RNXT | RenovoRx, Inc. | 1.36 | 0.06 (4.62%) | 49.74M | D |
| 519 | ALPN | Alpine Immune Sciences, Inc. | 64.97 | 0.01 (0.02%) | 4.46B | D |
| 520 | ENOB | Enochian Biosciences, Inc. | 0.70 | 0.00 (0.00%) | 40.80M | NR |
| 521 | PPBT | Purple Biotech Ltd | 2.48 | 0.08 (3.33%) | 3.30M | D |
| 522 | PYXS | Pyxis Oncology, Inc. | 1.10 | -0.10 (-8.33%) | 68.14M | D |
| 523 | OCUL | Ocular Therapeutix, Inc. | 9.62 | 0.16 (1.69%) | 1.53B | D |
| 524 | PTN | Palatin Technologies, Inc. | 0.09 | -0.08 (-44.65%) | 2.45M | D |
| 525 | AIM | AIM ImmunoTech Inc. | 8.85 | -0.32 (-3.47%) | 6.76M | NR |
| 526 | ROIV | Roivant Sciences Ltd. | 10.99 | 0.02 (0.18%) | 7.47B | D |
| 527 | NAVB | Navidea Biopharmaceuticals, Inc. | 0.00 | -0.00 (-80.00%) | 20.02K | NR |
| 528 | QURE | uniQure N.V. - Ordinary Shares | 14.42 | 0.14 (0.98%) | 789.87M | D |
| 529 | APDN | Applied DNA Sciences Inc | 4.63 | -0.31 (-6.19%) | 2.01M | D |
| 530 | XENE | Xenon Pharmaceuticals Inc. | 33.26 | -0.11 (-0.33%) | 2.55B | D |
| 531 | CVKD | Cadrenal Therapeutics Inc. | 12.98 | 0.54 (4.34%) | 25.53M | D |
| 532 | SNCA | Seneca Biopharma, Inc. | 1.66 | -0.02 (-1.19%) | 28.71M | NR |
| 533 | OKYO | OKYO Pharma Limited, | 2.78 | -0.13 (-4.47%) | 94.06M | D |
| 534 | AKRO | Akero Therapeutics, Inc. | 51.77 | -0.11 (-0.21%) | 4.13B | D |
| 535 | VOR | Vor Biopharma Inc. | 1.91 | 0.46 (31.72%) | 238.67M | D |
| 536 | MDWD | MediWound Ltd. - Ordinary Shares | 19.34 | 0.22 (1.15%) | 209.03M | D |
| 537 | BLUE | bluebird bio, Inc. | 4.97 | 0.23 (4.85%) | 48.67M | D |
| 538 | NBTX | Nanobiotix S.A. ADR | 4.87 | 0.14 (2.96%) | 229.54M | NR |
| 539 | PRVB | Provention Bio, Inc. | 24.98 | 0.75 (3.10%) | 2.37B | NR |
| 540 | SIOX | Sio Gene Therapies, Inc. | 0.48 | 0.01 (1.70%) | 34.87M | NR |
| 541 | AFMD | Affimed N.V. | 0.18 | -0.10 (-34.95%) | 2.92M | D |
| 542 | ACRV | Acrivon Therapeutics Inc. | 1.29 | 0.00 (0.00%) | 40.45M | D |
| 543 | CDTX | Cidara Therapeutics, Inc. | 48.78 | 0.91 (1.90%) | 983.60M | D |
| 544 | SMFR | Sema4 Holdings Corp. | 0.31 | 0.07 (26.78%) | 117.17M | NR |
| 545 | OGEN | Oragenics Inc. | 1.53 | 0.09 (6.25%) | 1.26M | D |
| 546 | ARPO | Aerpio Pharmaceuticals, Inc. | 2.20 | -0.02 (-0.90%) | 104.85M | NR |
| 547 | CYTK | Cytokinetics, Incorporated | 34.66 | 0.30 (0.87%) | 4.14B | D |
| 548 | TIL | Instil Bio, Inc. | 27.50 | 3.69 (15.50%) | 180.37M | D |
| 549 | CLRB | Cellectar Biosciences, Inc. | 4.80 | 0.07 (1.48%) | 8.69M | D |
| 550 | KLDO | Kaleido Biosciences, Inc. | 0.00 | 0.00 (0.00%) | 4.26K | NR |
| 551 | TPTX | Turning Point Therapeutics, Inc. - Common stock | 76.01 | 0.52 (0.69%) | 3.81B | NR |
| 552 | INM | InMed Pharmaceuticals Inc. | 2.91 | -0.14 (-4.59%) | 3.51M | D |
| 553 | BTTX | Better Therapeutics, Inc. | 0.00 | 0.00 (0.00%) | 4.99K | NR |
| 554 | OCGN | Ocugen Inc. | 0.96 | 0.03 (3.30%) | 279.47M | D |
| 555 | QLGN | Qualigen Therapeutics Inc | 3.16 | -0.10 (-3.19%) | 5.17M | D |
| 556 | LXXGF | Lexagene Holdings Inc. | 0.08 | -0.02 (-16.48%) | N/A | NR |
| 557 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 3.92 | -0.23 (-5.54%) | 12.41M | D |
| 558 | PHAT | PHATHOM PHARMACEUTICALS, INC. | 8.92 | 0.01 (0.11%) | 622.74M | D |
| 559 | NURO | NeuroMetrix, Inc. | 4.58 | 0.22 (5.05%) | 9.43M | NR |
| 560 | MNMD | Mind Medicine (MindMed) Inc. | 7.17 | 0.09 (1.27%) | 541.72M | D |
| 561 | CELU | Celularity Inc., | 1.98 | -0.05 (-2.46%) | 47.42M | D |
| 562 | SAVA | Cassava Sciences, Inc. | 2.01 | 0.00 (0.00%) | 97.10M | D |
| 563 | VERA | Vera Therapeutics, Inc. | 24.00 | 0.35 (1.48%) | 1.53B | D |
| 564 | CAPR | Capricor Therapeutics, Inc. | 10.25 | 0.23 (2.30%) | 468.19M | D |
| 565 | NRIX | Nurix Therapeutics Inc. | 12.73 | 0.29 (2.33%) | 970.48M | D |
| 566 | PROG | Progenity Inc. | 0.88 | -0.03 (-3.47%) | 162.92M | NR |
| 567 | ABVC | ABVC BioPharma, Inc. | 3.11 | 0.01 (0.32%) | 52.81M | D |
| 568 | IOVA | Iovance Biotherapeutics, Inc. | 1.75 | 0.00 (0.00%) | 584.38M | D |
| 569 | MRVI | Maravai LifeSciences | 2.67 | 0.02 (0.75%) | 679.94M | D |
| 570 | AUTL | Autolus Therapeutics plc - American Depositary Share | 2.37 | 0.02 (0.85%) | 630.75M | D |
| 571 | BCYC | Bicycle Therapeutics plc | 7.43 | -0.01 (-0.13%) | 514.56M | D |
| 572 | BEAM | Beam Therapeutics Inc. | 20.01 | 0.13 (0.65%) | 2.01B | D |
| 573 | AKTX | Akari Therapeutics Plc | 1.17 | 0.02 (1.30%) | 37.65M | NR |
| 574 | NVIV | InVivo Therapeutics Holdings Corp. | 0.32 | -0.17 (-34.28%) | 995.77K | NR |
| 575 | CDXS | Codexis, Inc. | 2.77 | -0.04 (-1.42%) | 229.48M | D |
| 576 | IMRX | Immuneering Corp | 3.45 | -0.14 (-3.90%) | 124.15M | D |
| 577 | GMDA | Gamida Cell Ltd. - Ordinary Shares | 0.03 | -0.01 (-18.25%) | 5.04M | NR |
| 578 | IMVT | Immunovant, Inc. | 16.95 | 0.14 (0.83%) | 2.90B | D |
| 579 | KRBP | Kiromic Biopharma Inc. | 0.16 | -0.15 (-48.74%) | 251.52K | NR |
| 580 | VLNCF | The Valens Company Inc. | 1.41 | -0.12 (-7.90%) | N/A | NR |
| 581 | MRTX | Mirati Therapeutics, Inc. | 58.70 | -0.10 (-0.17%) | 4.12B | NR |
| 582 | TNGX | Tango Therapeutics, Inc. | 5.70 | 0.05 (0.88%) | 617.85M | D |
| 583 | TFFP | TFF PHARMACEUTICALS, INC. | 0.07 | -0.10 (-60.05%) | 288.80K | D |
| 584 | EXAI | Exscientia Holdings Limited | 4.84 | 0.15 (3.20%) | 632.93M | D |
| 585 | SLNO | Soleno Therapeutics, Inc. | 86.65 | 0.44 (0.51%) | 4.37B | D |
| 586 | VINC | Vincerx Pharma, Inc. | 0.04 | -0.01 (-15.14%) | 199.42K | D |
| 587 | LGVN | Longeveron Inc. | 1.31 | 0.01 (0.77%) | 19.56M | D |
| 588 | LIFE | aTyr Pharma, Inc. | 1.90 | 0.05 (2.70%) | 131.12M | D |
| 589 | DYAI | Dyadic International, Inc. | 0.94 | 0.00 (0.00%) | 28.29M | D |
| 590 | ETNB | 89BIO, INC. | 10.16 | 0.06 (0.59%) | 1.48B | D |
| 591 | ISEE | IVERIC bio, Inc. | 39.95 | 0.15 (0.38%) | 5.50B | NR |
| 592 | AZRX | AzurRx BioPharma, Inc. | 3.45 | 0.07 (2.07%) | 32.17M | NR |
| 593 | REVB | Revelation Biosciences, Inc., | 0.76 | -0.01 (-1.31%) | 3.50M | D |
| 594 | APTO | Aptose Biosciences, Inc. | 1.71 | -1.44 (-45.71%) | 3.66M | D |
| 595 | AXLA | Axcella Health Inc. | 0.40 | -0.04 (-8.89%) | 1.18M | NR |
| 596 | LIPO | Lipella Pharmaceuticals Inc. | 0.78 | -0.04 (-4.85%) | 3.48M | D |
| 597 | CYDY | CytoDyn Inc. | 0.29 | 0.02 (5.56%) | 356.69M | NR |
| 598 | FDMT | 4D Molecular Therapeutics Inc. | 4.24 | -0.07 (-1.62%) | 196.42M | D |
| 599 | PGEN | Precigen, Inc. | 1.62 | 0.01 (0.62%) | 478.19M | D |
| 600 | HUMA | Humacyte, Inc. | 2.28 | -0.03 (-1.30%) | 353.67M | D |
| 601 | LRMR | Larimar Therapeutics, Inc. | 3.20 | 0.09 (2.89%) | 204.89M | D |
| 602 | KTTA | Pasithea Therapeutics Corp. | 0.73 | -0.02 (-2.09%) | 5.45M | D |
| 603 | CRSP | CRISPR Therapeutics AG | 52.17 | 0.50 (0.97%) | 4.51B | F |
| 604 | NTLA | Intellia Therapeutics, Inc. | 10.74 | 0.01 (0.09%) | 1.11B | D |
| 605 | ABSI | AbSci Corp | 2.77 | 0.08 (2.97%) | 353.34M | F |
| 606 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 7.71 | -0.04 (-0.52%) | 94.35M | F |
| 607 | DICE | DICE Therapeutics, Inc. | 47.55 | 0.03 (0.06%) | 2.27B | NR |
| 608 | XCUR | Exicure, Inc. | 6.78 | 0.82 (13.76%) | 42.84M | F |
| 609 | INMB | INmune Bio Inc. - Common stock | 2.53 | 0.17 (7.20%) | 59.67M | F |
| 610 | ZSAN | Zosano Pharma Corporation | 0.56 | 0.04 (7.23%) | 2.73M | NR |
| 611 | ALT | Altimmune, Inc. | 4.76 | -0.14 (-2.86%) | 386.07M | F |
| 612 | PRPH | ProPhase Labs, Inc. | 0.42 | 0.01 (3.67%) | 17.38M | F |
| 613 | JSPR | Jasper Therapeutics, Inc., | 6.77 | -0.05 (-0.73%) | 101.70M | F |
| 614 | BXRX | Baudax Bio, Inc. | 0.02 | 0.00 (7.39%) | 1.14M | NR |
| 615 | APVO | Aptevo Therapeutics Inc. | 3.04 | 0.00 (0.00%) | 2.30M | F |
| 616 | TBIO | Translate Bio, Inc. | 0.30 | 0.20 (200.00%) | 540.60K | F |
| 617 | CTXR | Citius Pharmaceuticals, Inc. | 2.21 | 0.11 (5.24%) | 23.50M | F |
| 618 | RANI | Rani Therapeutics Holdings, Inc. | 0.54 | 0.00 (0.68%) | 30.78M | F |
| 619 | DYN | Dyne Therapeutics, Inc. | 8.76 | -0.18 (-2.01%) | 995.72M | F |
| 620 | KRTX | Karuna Therapeutics, Inc. | 329.83 | 0.09 (0.03%) | 12.58B | NR |
| 621 | ADTX | ADiTx Therapeutics Inc. | 1.23 | -0.02 (-1.60%) | 2.61M | F |
| 622 | CMRA | Comera Life Sciences Holdings, Inc. | 0.00 | 0.00 (0.00%) | 6.15K | NR |
| 623 | LPTX | Leap Therapeutics, Inc. | 0.29 | 0.00 (1.18%) | 12.08M | F |
| 624 | PRME | Prime Medicine Inc. | 3.11 | 0.04 (1.30%) | 408.32M | F |
| 625 | VRPX | Virpax Pharmaceuticals, Inc. | 0.39 | -0.01 (-2.77%) | 483.14K | F |
| 626 | CABA | CABALETTA BIO, INC. | 1.63 | 0.03 (1.87%) | 82.71M | F |
| 627 | PRAX | Praxis Precision Medicines Inc. | 47.26 | 0.94 (2.03%) | 962.64M | F |
| 628 | AKER | Akers Biosciences Inc. | 2.47 | -0.26 (-9.52%) | 41.13M | NR |
| 629 | CYBN | Cybin Inc. | 7.94 | 0.56 (7.59%) | 182.81M | F |
| 630 | SANA | Sana Biotechnology, Inc. | 3.19 | 0.27 (9.25%) | 719.27M | F |
| 631 | CBUS | Cibus Inc. | 1.55 | 0.04 (2.65%) | 50.62M | F |
| 632 | IBIO | iBio, Inc. | 0.74 | 0.00 (0.14%) | 12.24M | F |
| 633 | TYHT | Shineco, Inc. | 11.09 | -0.45 (-3.90%) | 97.24M | NR |
| 634 | ABCL | AbCellera Biologics Inc. | 3.80 | 0.05 (1.33%) | 1.13B | F |
| 635 | AGFY | Agrify Corporation | 21.03 | -1.74 (-7.64%) | 41.05M | F |
| 636 | QSI | Quantum-Si incorporated | 2.14 | 0.16 (8.08%) | 392.69M | F |
| 637 | CRDF | Cardiff Oncology, Inc. | 3.66 | 0.07 (1.95%) | 243.49M | F |
| 638 | BFRG | Bullfrog AI Holdings Inc. | 1.63 | 0.05 (3.16%) | 15.35M | F |
| 639 | CLDX | Celldex Therapeutics Inc. | 22.00 | -0.11 (-0.50%) | 1.46B | F |
| 640 | RNA | Avidity Biosciences Inc. | 29.17 | -0.19 (-0.65%) | 3.52B | F |
| NR | ANACU | Anacor Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| NR | RVVTF | Revive Therapeutics Ltd. | 0.02 | -0.00 (-3.01%) | N/A | NR |
| NR | RCOR | Renovacor, Inc., | 3.20 | 0.15 (4.92%) | 55.26M | NR |
| NR | VLNS | Valens Co. Inc. | 0.76 | 0.00 (0.03%) | 61.38M | NR |
| NR | RSCF | Reflect Scientific Inc. | 0.07 | 0.01 (7.91%) | N/A | NR |
| NR | ANTH | Anthera Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| NR | SPHS | Sophiris Bio, Inc. | 0.00 | 0.00 (0.00%) | 3.56K | NR |
| NR | ENZN | Enzon Pharmaceuticals | 0.11 | 0.00 (1.95%) | 8.53M | NR |
| NR | CYAD | Celyad SA | 0.47 | -0.06 (-11.10%) | 10.62M | NR |
| NR | AMRH | Enveric Biosciences Inc. | 1.48 | -0.22 (-12.94%) | 11.09M | NR |
| NR | PHGE | BiomX Inc. | 0.44 | 0.00 (0.00%) | 11.52M | NR |
| NR | NVUS | Eledon Pharmaceuticals, Inc. | 14.60 | -0.80 (-5.19%) | 20.97M | NR |
| NR | KMPHD | KemPharm, Inc. | 8.25 | -1.06 (-11.39%) | 35.60M | NR |
| NR | ICCC | ImmuCell Corporation | 6.39 | 0.01 (0.08%) | 57.75M | NR |
| NR | MGEN | Miragen Therapeutics, Inc. | 23.01 | -0.02 (-0.09%) | 89.92M | NR |
| NR | XYNO | Xynomic Pharmaceuticals Holdings, Inc. | 2.22 | 0.06 (2.78%) | 102.73M | NR |
| NR | PDLI | PDL BioPharma, Inc. | 2.47 | -0.23 (-8.52%) | 282.14M | NR |
| NR | HQL | Tekla Life Sciences Investors | 13.09 | 0.07 (0.54%) | 377.93M | NR |
| NR | OPT | Opthea Ltd. ADR | 3.41 | 0.23 (7.23%) | 524.84M | NR |
| NR | PHAR | Pharming Group NV | 10.58 | -0.07 (-0.66%) | 719.77M | NR |
| NR | PRVL | Prevail Therapeutics Inc. - common stock | 23.00 | -0.02 (-0.09%) | 787.66M | NR |
All price changes on this page include dividends and splits.